世界と中国の向精神薬市場規模・現状・見通し2021-2027年Global and China Psychotropic Drug Market Size, Status and Forecast 2021-2027 必須の向精神薬の大部分は、精神障害の症状を治療し、精神障害の進行を遅らせ、障害を軽減し、患者の再発を避けるために使用されます。 市場分析と洞察。向精神薬の世界市場 向精神薬の世界市場規模は、2020... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー必須の向精神薬の大部分は、精神障害の症状を治療し、精神障害の進行を遅らせ、障害を軽減し、患者の再発を避けるために使用されます。市場分析と洞察。向精神薬の世界市場 向精神薬の世界市場規模は、2020年のXX百万米ドルから、2021-2027年の間にXX%のCAGRで、2027年にXX百万米ドルに達すると予測されます。 本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の向精神薬市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での向精神薬の世界市場全体のサイズも含まれています。 本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の向精神薬市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の向精神薬市場を詳細に調査するために、独自の業界最高の調査・分析手法を用いています。 世界の向精神薬の範囲と市場規模 向精神薬市場は、企業別、地域(国)別、タイプ別、用途別に分類されています。世界の向精神薬市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間におけるタイプ別、アプリケーション別の収益と予測に焦点を当てています。 タイプ別セグメント 鎮痛剤 麻酔薬(Anesthetics 催眠剤 その他 用途別セグメント 病院薬局 小売薬局 オンライン薬局 地域別 北アメリカ U.S. カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア 北欧 その他のヨーロッパ諸国 アジア太平洋地域 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア諸国 ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中近東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他の中東・アフリカ地域 会社別 ファイザー イーライリリー Actavis マイラン ランドックス 富士フイルム 目次1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Psychotropic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Analgesics 1.2.3 Anesthetics 1.2.4 Hypnotics 1.2.5 Others 1.3 Market by Application 1.3.1 Global Psychotropic Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Psychotropic Drug Market Perspective (2016-2027) 2.2 Psychotropic Drug Growth Trends by Regions 2.2.1 Psychotropic Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Psychotropic Drug Historic Market Share by Regions (2016-2021) 2.2.3 Psychotropic Drug Forecasted Market Size by Regions (2022-2027) 2.3 Psychotropic Drug Industry Dynamic 2.3.1 Psychotropic Drug Market Trends 2.3.2 Psychotropic Drug Market Drivers 2.3.3 Psychotropic Drug Market Challenges 2.3.4 Psychotropic Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Psychotropic Drug Players by Revenue 3.1.1 Global Top Psychotropic Drug Players by Revenue (2016-2021) 3.1.2 Global Psychotropic Drug Revenue Market Share by Players (2016-2021) 3.2 Global Psychotropic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Psychotropic Drug Revenue 3.4 Global Psychotropic Drug Market Concentration Ratio 3.4.1 Global Psychotropic Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Psychotropic Drug Revenue in 2020 3.5 Psychotropic Drug Key Players Head office and Area Served 3.6 Key Players Psychotropic Drug Product Solution and Service 3.7 Date of Enter into Psychotropic Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Psychotropic Drug Breakdown Data by Type 4.1 Global Psychotropic Drug Historic Market Size by Type (2016-2021) 4.2 Global Psychotropic Drug Forecasted Market Size by Type (2022-2027) 5 Psychotropic Drug Breakdown Data by Application 5.1 Global Psychotropic Drug Historic Market Size by Application (2016-2021) 5.2 Global Psychotropic Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Psychotropic Drug Market Size (2016-2027) 6.2 North America Psychotropic Drug Market Size by Type 6.2.1 North America Psychotropic Drug Market Size by Type (2016-2021) 6.2.2 North America Psychotropic Drug Market Size by Type (2022-2027) 6.2.3 North America Psychotropic Drug Market Size by Type (2016-2027) 6.3 North America Psychotropic Drug Market Size by Application 6.3.1 North America Psychotropic Drug Market Size by Application (2016-2021) 6.3.2 North America Psychotropic Drug Market Size by Application (2022-2027) 6.3.3 North America Psychotropic Drug Market Size by Application (2016-2027) 6.4 North America Psychotropic Drug Market Size by Country 6.4.1 North America Psychotropic Drug Market Size by Country (2016-2021) 6.4.2 North America Psychotropic Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Psychotropic Drug Market Size (2016-2027) 7.2 Europe Psychotropic Drug Market Size by Type 7.2.1 Europe Psychotropic Drug Market Size by Type (2016-2021) 7.2.2 Europe Psychotropic Drug Market Size by Type (2022-2027) 7.2.3 Europe Psychotropic Drug Market Size by Type (2016-2027) 7.3 Europe Psychotropic Drug Market Size by Application 7.3.1 Europe Psychotropic Drug Market Size by Application (2016-2021) 7.3.2 Europe Psychotropic Drug Market Size by Application (2022-2027) 7.3.3 Europe Psychotropic Drug Market Size by Application (2016-2027) 7.4 Europe Psychotropic Drug Market Size by Country 7.4.1 Europe Psychotropic Drug Market Size by Country (2016-2021) 7.4.2 Europe Psychotropic Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Psychotropic Drug Market Size (2016-2027) 8.2 Asia-Pacific Psychotropic Drug Market Size by Type 8.2.1 Asia-Pacific Psychotropic Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Psychotropic Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Psychotropic Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Psychotropic Drug Market Size by Application 8.3.1 Asia-Pacific Psychotropic Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Psychotropic Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Psychotropic Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Psychotropic Drug Market Size by Region 8.4.1 Asia-Pacific Psychotropic Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Psychotropic Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Psychotropic Drug Market Size (2016-2027) 9.2 Latin America Psychotropic Drug Market Size by Type 9.2.1 Latin America Psychotropic Drug Market Size by Type (2016-2021) 9.2.2 Latin America Psychotropic Drug Market Size by Type (2022-2027) 9.2.3 Latin America Psychotropic Drug Market Size by Type (2016-2027) 9.3 Latin America Psychotropic Drug Market Size by Application 9.3.1 Latin America Psychotropic Drug Market Size by Application (2016-2021) 9.3.2 Latin America Psychotropic Drug Market Size by Application (2022-2027) 9.3.3 Latin America Psychotropic Drug Market Size by Application (2016-2027) 9.4 Latin America Psychotropic Drug Market Size by Country 9.4.1 Latin America Psychotropic Drug Market Size by Country (2016-2021) 9.4.2 Latin America Psychotropic Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Psychotropic Drug Market Size (2016-2027) 10.2 Middle East & Africa Psychotropic Drug Market Size by Type 10.2.1 Middle East & Africa Psychotropic Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Psychotropic Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Psychotropic Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Psychotropic Drug Market Size by Application 10.3.1 Middle East & Africa Psychotropic Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Psychotropic Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Psychotropic Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Psychotropic Drug Market Size by Country 10.4.1 Middle East & Africa Psychotropic Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Psychotropic Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Psychotropic Drug Introduction 11.1.4 Pfizer Revenue in Psychotropic Drug Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Ely Lilly 11.2.1 Ely Lilly Company Details 11.2.2 Ely Lilly Business Overview 11.2.3 Ely Lilly Psychotropic Drug Introduction 11.2.4 Ely Lilly Revenue in Psychotropic Drug Business (2016-2021) 11.2.5 Ely Lilly Recent Development 11.3 Actavis 11.3.1 Actavis Company Details 11.3.2 Actavis Business Overview 11.3.3 Actavis Psychotropic Drug Introduction 11.3.4 Actavis Revenue in Psychotropic Drug Business (2016-2021) 11.3.5 Actavis Recent Development 11.4 Mylan 11.4.1 Mylan Company Details 11.4.2 Mylan Business Overview 11.4.3 Mylan Psychotropic Drug Introduction 11.4.4 Mylan Revenue in Psychotropic Drug Business (2016-2021) 11.4.5 Mylan Recent Development 11.5 Randox 11.5.1 Randox Company Details 11.5.2 Randox Business Overview 11.5.3 Randox Psychotropic Drug Introduction 11.5.4 Randox Revenue in Psychotropic Drug Business (2016-2021) 11.5.5 Randox Recent Development 11.6 Fujifilm 11.6.1 Fujifilm Company Details 11.6.2 Fujifilm Business Overview 11.6.3 Fujifilm Psychotropic Drug Introduction 11.6.4 Fujifilm Revenue in Psychotropic Drug Business (2016-2021) 11.6.5 Fujifilm Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
SummaryThe majority of essential psychotropic drugs are indicated to treat symptoms of mental disorders, slow down course of mental disorders, diminish disability and avoid relapse in a patient. Table of Contents1 Report Overview1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Psychotropic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Analgesics 1.2.3 Anesthetics 1.2.4 Hypnotics 1.2.5 Others 1.3 Market by Application 1.3.1 Global Psychotropic Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Psychotropic Drug Market Perspective (2016-2027) 2.2 Psychotropic Drug Growth Trends by Regions 2.2.1 Psychotropic Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Psychotropic Drug Historic Market Share by Regions (2016-2021) 2.2.3 Psychotropic Drug Forecasted Market Size by Regions (2022-2027) 2.3 Psychotropic Drug Industry Dynamic 2.3.1 Psychotropic Drug Market Trends 2.3.2 Psychotropic Drug Market Drivers 2.3.3 Psychotropic Drug Market Challenges 2.3.4 Psychotropic Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Psychotropic Drug Players by Revenue 3.1.1 Global Top Psychotropic Drug Players by Revenue (2016-2021) 3.1.2 Global Psychotropic Drug Revenue Market Share by Players (2016-2021) 3.2 Global Psychotropic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Psychotropic Drug Revenue 3.4 Global Psychotropic Drug Market Concentration Ratio 3.4.1 Global Psychotropic Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Psychotropic Drug Revenue in 2020 3.5 Psychotropic Drug Key Players Head office and Area Served 3.6 Key Players Psychotropic Drug Product Solution and Service 3.7 Date of Enter into Psychotropic Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Psychotropic Drug Breakdown Data by Type 4.1 Global Psychotropic Drug Historic Market Size by Type (2016-2021) 4.2 Global Psychotropic Drug Forecasted Market Size by Type (2022-2027) 5 Psychotropic Drug Breakdown Data by Application 5.1 Global Psychotropic Drug Historic Market Size by Application (2016-2021) 5.2 Global Psychotropic Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Psychotropic Drug Market Size (2016-2027) 6.2 North America Psychotropic Drug Market Size by Type 6.2.1 North America Psychotropic Drug Market Size by Type (2016-2021) 6.2.2 North America Psychotropic Drug Market Size by Type (2022-2027) 6.2.3 North America Psychotropic Drug Market Size by Type (2016-2027) 6.3 North America Psychotropic Drug Market Size by Application 6.3.1 North America Psychotropic Drug Market Size by Application (2016-2021) 6.3.2 North America Psychotropic Drug Market Size by Application (2022-2027) 6.3.3 North America Psychotropic Drug Market Size by Application (2016-2027) 6.4 North America Psychotropic Drug Market Size by Country 6.4.1 North America Psychotropic Drug Market Size by Country (2016-2021) 6.4.2 North America Psychotropic Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Psychotropic Drug Market Size (2016-2027) 7.2 Europe Psychotropic Drug Market Size by Type 7.2.1 Europe Psychotropic Drug Market Size by Type (2016-2021) 7.2.2 Europe Psychotropic Drug Market Size by Type (2022-2027) 7.2.3 Europe Psychotropic Drug Market Size by Type (2016-2027) 7.3 Europe Psychotropic Drug Market Size by Application 7.3.1 Europe Psychotropic Drug Market Size by Application (2016-2021) 7.3.2 Europe Psychotropic Drug Market Size by Application (2022-2027) 7.3.3 Europe Psychotropic Drug Market Size by Application (2016-2027) 7.4 Europe Psychotropic Drug Market Size by Country 7.4.1 Europe Psychotropic Drug Market Size by Country (2016-2021) 7.4.2 Europe Psychotropic Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Psychotropic Drug Market Size (2016-2027) 8.2 Asia-Pacific Psychotropic Drug Market Size by Type 8.2.1 Asia-Pacific Psychotropic Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Psychotropic Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Psychotropic Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Psychotropic Drug Market Size by Application 8.3.1 Asia-Pacific Psychotropic Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Psychotropic Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Psychotropic Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Psychotropic Drug Market Size by Region 8.4.1 Asia-Pacific Psychotropic Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Psychotropic Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Psychotropic Drug Market Size (2016-2027) 9.2 Latin America Psychotropic Drug Market Size by Type 9.2.1 Latin America Psychotropic Drug Market Size by Type (2016-2021) 9.2.2 Latin America Psychotropic Drug Market Size by Type (2022-2027) 9.2.3 Latin America Psychotropic Drug Market Size by Type (2016-2027) 9.3 Latin America Psychotropic Drug Market Size by Application 9.3.1 Latin America Psychotropic Drug Market Size by Application (2016-2021) 9.3.2 Latin America Psychotropic Drug Market Size by Application (2022-2027) 9.3.3 Latin America Psychotropic Drug Market Size by Application (2016-2027) 9.4 Latin America Psychotropic Drug Market Size by Country 9.4.1 Latin America Psychotropic Drug Market Size by Country (2016-2021) 9.4.2 Latin America Psychotropic Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Psychotropic Drug Market Size (2016-2027) 10.2 Middle East & Africa Psychotropic Drug Market Size by Type 10.2.1 Middle East & Africa Psychotropic Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Psychotropic Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Psychotropic Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Psychotropic Drug Market Size by Application 10.3.1 Middle East & Africa Psychotropic Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Psychotropic Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Psychotropic Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Psychotropic Drug Market Size by Country 10.4.1 Middle East & Africa Psychotropic Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Psychotropic Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Psychotropic Drug Introduction 11.1.4 Pfizer Revenue in Psychotropic Drug Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Ely Lilly 11.2.1 Ely Lilly Company Details 11.2.2 Ely Lilly Business Overview 11.2.3 Ely Lilly Psychotropic Drug Introduction 11.2.4 Ely Lilly Revenue in Psychotropic Drug Business (2016-2021) 11.2.5 Ely Lilly Recent Development 11.3 Actavis 11.3.1 Actavis Company Details 11.3.2 Actavis Business Overview 11.3.3 Actavis Psychotropic Drug Introduction 11.3.4 Actavis Revenue in Psychotropic Drug Business (2016-2021) 11.3.5 Actavis Recent Development 11.4 Mylan 11.4.1 Mylan Company Details 11.4.2 Mylan Business Overview 11.4.3 Mylan Psychotropic Drug Introduction 11.4.4 Mylan Revenue in Psychotropic Drug Business (2016-2021) 11.4.5 Mylan Recent Development 11.5 Randox 11.5.1 Randox Company Details 11.5.2 Randox Business Overview 11.5.3 Randox Psychotropic Drug Introduction 11.5.4 Randox Revenue in Psychotropic Drug Business (2016-2021) 11.5.5 Randox Recent Development 11.6 Fujifilm 11.6.1 Fujifilm Company Details 11.6.2 Fujifilm Business Overview 11.6.3 Fujifilm Psychotropic Drug Introduction 11.6.4 Fujifilm Revenue in Psychotropic Drug Business (2016-2021) 11.6.5 Fujifilm Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(抗感染性薬物)の最新刊レポートQYResearch社のその他分野での最新刊レポート
本レポートと同じKEY WORD(drug)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |